75 related articles for article (PubMed ID: 31018952)
1. Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic Sarcomas Identified by Targeted Next-generation Sequencing.
Zheng B; Qu Y; Wang J; Shi Y; Yan W
Cancer Genomics Proteomics; 2019; 16(3):221-228. PubMed ID: 31018952
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma.
Williams EA; Vegas I; El-Senduny FF; Zhang J; Mata DA; Hiemenz MC; Hughes SR; Sa BC; Kraft GP; Gorbatov N; Foley-Peres K; Sanchez EZ; Milikowski C; Williams KJ; Ross JS; Kurzrock R; Montgomery EA; Lombard DB; Kumar S
Am J Surg Pathol; 2024 Jun; 48(6):699-707. PubMed ID: 38369783
[TBL] [Abstract][Full Text] [Related]
3. Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma.
Saoud C; Dermawan JK; Sharma AE; Tap W; Wexler LH; Antonescu CR
Genes Chromosomes Cancer; 2024 May; 63(5):e23238. PubMed ID: 38722224
[TBL] [Abstract][Full Text] [Related]
4. Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response.
Kasago IS; Chatila WK; Lezcano CM; Febres-Aldana CA; Schultz N; Vanderbilt C; Dogan S; Bartlett EK; D'Angelo SP; Tap WD; Singer S; Ladanyi M; Shoushtari AN; Busam KJ; Hameed M
Mod Pathol; 2023 Aug; 36(8):100165. PubMed ID: 36990277
[TBL] [Abstract][Full Text] [Related]
5. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
[TBL] [Abstract][Full Text] [Related]
6. Anti-PD-1 elicits regression of undifferentiated pleomorphic sarcomas with UV-mutation signatures.
Cheung LS; Chen L; Oke TF; Schaffer TB; Boudadi K; Ngo JT; Gross JM; Kemberling H; Diaz LA; Lipson E; Sidhom JW; Taube J; Anders R; Pardoll DM; Le DT; Meyer CF; Llosa N
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34103354
[TBL] [Abstract][Full Text] [Related]
7.
Nassif EF; Auclin E; Bahleda R; Honoré C; Mir O; Dumont S; Mery B; Hodroj K; Brahmi M; Trédan O; Ray-Coquard I; Blay JY; Massard C; Le Cesne A; Dufresne A
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282771
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing for the management of sarcomas with no known driver mutations.
Vyse S; Thway K; Huang PH; Jones RL
Curr Opin Oncol; 2021 Jul; 33(4):315-322. PubMed ID: 33927108
[TBL] [Abstract][Full Text] [Related]
9. A novel next generation sequencing approach to improve sarcoma diagnosis.
McConnell L; Houghton O; Stewart P; Gazdova J; Srivastava S; Kim C; Catherwood M; Strobl A; Flanagan AM; Oniscu A; Kroeze LI; Groenen P; Taniere P; Salto-Tellez M; Gonzalez D
Mod Pathol; 2020 Jul; 33(7):1350-1359. PubMed ID: 32047232
[TBL] [Abstract][Full Text] [Related]
10. Single-cell landscape of undifferentiated pleomorphic sarcoma.
Lu Y; Chen D; Wang B; Chai W; Yan M; Chen Y; Zhan Y; Yang R; Zhou E; Dai S; Li Y; Dong R; Zheng B
Oncogene; 2024 May; 43(18):1353-1368. PubMed ID: 38459120
[TBL] [Abstract][Full Text] [Related]
11. Mouse genetic background influences whether
Brandt LP; Albers J; Hejhal T; Pfundstein S; Gonçalves AF; Catalano A; Wild PJ; Frew IJ
Oncotarget; 2018 Apr; 9(28):19753-19766. PubMed ID: 29731980
[TBL] [Abstract][Full Text] [Related]
12. ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas.
Darmusey L; Pérot G; Thébault N; Le Guellec S; Desplat N; Gaston L; Delespaul L; Lesluyes T; Darbo E; Gomez-Brouchet A; Richard E; Baud J; Leroy L; Coindre JM; Blay JY; Chibon F
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33946962
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Genomic Profiling of Adult Renal Sarcomas Provides Insight into Disease Biology and Opportunities for Targeted Therapies.
Yakirevich E; Madison R; Fridman E; Mangray S; Carneiro BA; Lu S; Cooke M; Bratslavsky G; Webster J; Ross JS; Ali SM
Eur Urol Oncol; 2021 Apr; 4(2):282-288. PubMed ID: 31412008
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Fusion Transcripts in Undifferentiated Pleomorphic Sarcomas by Transcriptome Sequencing.
Zheng B; Zhang S; Cai W; Wang J; Wang T; Tang N; Shi Y; Luo X; Yan W
Cancer Genomics Proteomics; 2019; 16(5):399-408. PubMed ID: 31467233
[TBL] [Abstract][Full Text] [Related]
15. Immune checkpoint inhibitors in sarcomas: a systematic review.
Anastasiou M; Kyriazoglou A; Kotsantis I; Economopoulou P; Kyrkasiadou M; Giannopoulou A; Kosmidou A; Smerdi D; Moutafi M; Gavrielatou N; Psyrri A
Immunooncol Technol; 2023 Dec; 20():100407. PubMed ID: 38192615
[TBL] [Abstract][Full Text] [Related]
16. A case of adrenal undifferentiated pleomorphic sarcoma with tertiary lymphoid structures responded to pembrolizumab.
Kokubun H; Kijima T; Takada-Owada A; Mamiya D; Kurashina R; Okubo N; Uematsu T; Takei K; Ishida K; Kamai T
IJU Case Rep; 2023 Nov; 6(6):440-444. PubMed ID: 37928308
[TBL] [Abstract][Full Text] [Related]
17. Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma.
Sun H; Liu J; Hu F; Xu M; Leng A; Jiang F; Chen K
Front Genet; 2023; 14():1109491. PubMed ID: 36873946
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and Tolerability of Anlotinib Plus PD-1 Inhibitors for Patients with Previously Treated Metastatic Soft-Tissue Sarcoma.
Sun X; Xu J; Xie L; Guo W
Int J Gen Med; 2022; 15():7581-7591. PubMed ID: 36196372
[TBL] [Abstract][Full Text] [Related]
19. Next Generation Sequencing Reveals Pathogenic and Actionable Genetic Alterations of Soft Tissue Sarcoma in Chinese Patients: A Single Center Experience.
Jin G; Wang C; Jia D; Qian W; Yin C; Wang D; Yang Q; Li T; Zheng A
Technol Cancer Res Treat; 2021; 20():15330338211068964. PubMed ID: 34939467
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
